| 2022 | Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease
| GUT AND LIVER |
| 2022 | Dapagliflozin attenuates diabetes-induced diastolic dysfunction and cardiac fibrosis by regulating SGK1 signaling
| BMC MEDICINE |
| 2022 | The effects of the voglibose on non-alcoholic fatty liver disease in mice model
| SCIENTIFIC REPORTS |
| 2022 | Protective Effect of Delta-Like 1 Homolog Against Muscular Atrophy in a Mouse Model
| Endocrinology and Metabolism(대한내분비학회지) |
| 2022 | Effects of a Phosphodiesterase inhibitor on the Browning of Adipose Tissue in Mice
| BIOMEDICINES |
| 2022 | Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
| DIABETES & METABOLISM JOURNAL |
| 2022 | Differences in complication patterns in subgroups of type 2 diabetes according to insulin resistance and beta-cell function
| SCIENTIFIC REPORTS |
| 2022 | A GLP-1/GLP-2 receptor dual agonist to treat NASH: Targeting the gut-liver axis and microbiome | HEPATOLOGY |
| 2022 | Sodium Glucose Cotransporter-2 Inhibitors as an Add-on Therapy to Metformin Plus Dipeptidyl Peptidase-4 Inhibitor in Patients with Type 2 Diabetes
| YONSEI MEDICAL JOURNAL |
| 2022 | Association of Metabolomic Change and Treatment Response in Patients with Non-Alcoholic Fatty Liver Disease
| BIOMEDICINES |
| 2022 | The predicting value of resting heart rate to identify undiagnosed diabetes in Korean adult: Korea National Health and Nutrition Examination Survey
| EPIDEMIOLOGY AND HEALTH |
| 2022 | Inhibition of CXXC5 function reverses obesity-related metabolic diseases
| CLINICAL AND TRANSLATIONAL MEDICINE |
| 2022 | Short Term Isocaloric Ketogenic Diet Modulates NLRP3 Inflammasome Via B-hydroxybutyrate and Fibroblast Growth Factor 21
| FRONTIERS IN IMMUNOLOGY |
| 2022 | Severe Hypoglycemia Increases Dementia Risk and Related Mortality: A Nationwide, Population-based Cohort Study | JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM |
| 2022 | Ideal cardiovascular health duration and risk of chronic kidney disease and cardiovascular disease | HEART |
| 2022 | Performance of Diabetes and Kidney Disease Screening Scores in Contemporary United States and Korean Populations
| DIABETES & METABOLISM JOURNAL |
| 2022 | Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study)
| BMC MEDICINE |
| 2022 | Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
| GUT AND LIVER |
| 2022 | State-of-the-Art Overview of the Pharmacological Treatment of Non-Alcoholic Steatohepatitis
| Endocrinology and Metabolism(대한내분비학회지) |
| 2022 | Analysis of Severe Hypoglycemia Among Adults With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
| JAMA NETWORK OPEN |
| 2022 | Renal Tubular Damage Marker, Urinary N-acetyl-β-D-Glucosaminidase, as a Predictive Marker of Hepatic Fibrosis in Type 2 Diabetes Mellitus
| DIABETES & METABOLISM JOURNAL |
| 2022 | Blood Pressure Levels and Risks of Dementia: a Nationwide Study of 4.5 Million People | HYPERTENSION |
| 2021 | The Leg Fat to Total Fat Ratio Is Associated with Lower Risks of Non-Alcoholic Fatty Liver Disease and Less Severe Hepatic Fibrosis: Results from Nationwide Surveys (KNHANES 2008–2011)
| Endocrinology and Metabolism(대한내분비학회지) |
| 2021 | Uric Acid Variability as a Predictive Marker of Newly Developed Cardiovascular Events in Type 2 Diabetes
| FRONTIERS IN CARDIOVASCULAR MEDICINE |
| 2021 | Proteinuria as a significant predictive factor for the progression of carotid artery atherosclerosis in non-albuminuric type 2 diabetes | DIABETES RESEARCH AND CLINICAL PRACTICE |
| 2021 | Ipragliflozin, an SGLT2 Inhibitor, Ameliorates High-Fat Diet-Induced Metabolic Changes by Upregulating Energy Expenditure through Activation of the AMPK/ SIRT1 Pathway
| DIABETES & METABOLISM JOURNAL |
| 2021 | Real-world evidence on the strategy of olmesartan-based triple single-pill combination in Korean hypertensive patients: a prospective, multicenter, observational study (RESOLVE-PRO)
| Clinical Hypertension |
| 2021 | Association of circulating metabolites with incident type 2 diabetes in an obese population from a national cohort | DIABETES RESEARCH AND CLINICAL PRACTICE |
| 2021 | Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
| 2021 | Body Weight Variability: A Marker for Increased Risk or a Causative Factor for Dementia?
| JOURNAL OF OBESITY & METABOLIC SYNDROME |
| 2021 | Role of DPP-4 and SGLT2 Inhibitors Connected to Alzheimer Disease in Type 2 Diabetes Mellitus
| FRONTIERS IN NEUROSCIENCE |
| 2021 | Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts
| Endocrinology and Metabolism(대한내분비학회지) |
| 2021 | Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetes | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2021 | Risks and Prognoses of Alzheimer's Disease and Vascular Dementia in Patients With Insomnia: A Nationwide Population-Based Study
| FRONTIERS IN NEUROLOGY |
| 2021 | Nonalcoholic fatty liver disease, diastolic dysfunction, and impaired myocardial glucose uptake in patients with type 2 diabetes | DIABETES OBESITY & METABOLISM |
| 2021 | Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) | AUTOPHAGY |
| 2021 | O- Linked N-Acetylglucosamine Modification of Mitochondrial Antiviral Signaling Protein Regulates Antiviral Signaling by Modulating Its Activity
| FRONTIERS IN IMMUNOLOGY |
| 2021 | Glycaemic control with add-on thiazolidinedione or a sodium-glucose co-transporter-2 inhibitor in patients with type 2 diabetes after the failure of an oral triple antidiabetic regimen: A 24-week, randomized controlled trial | DIABETES OBESITY & METABOLISM |
| 2020 | Metformin and Gastrointestinal Cancer Development in Newly Diagnosed Type 2 Diabetes: A Population-Based Study in Korea
| CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY |
| 2020 | Association between liver fibrosis and appendicular skeletal muscle mass during antiviral therapy in chronic hepatitis B | DIGESTIVE AND LIVER DISEASE |
| 2020 | Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus
| DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY |
| 2020 | SQSTM1/p62 activates NFE2L2/NRF2 via ULK1-mediated autophagic KEAP1 degradation and protects mouse liver from lipotoxicity | AUTOPHAGY |
| 2020 | Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression
| SCIENTIFIC REPORTS |
| 2020 | Pharmaceutical Efficacy of Gypenoside LXXV on Non-Alcoholic Steatohepatitis (NASH)
| BIOMOLECULES |
| 2020 | Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes | DIABETES & METABOLISM |
| 2020 | Mechanisms of Sodium-Glucose Cotransporter 2 Inhibition: Insights From Large-Scale Proteomics | DIABETES CARE |
| 2020 | Hepatic fibrosis is associated with total proteinuria in Korean patients with type 2 diabetes
| MEDICINE |
| 2020 | Low muscle mass is associated with carotid atherosclerosis in patients with type 2 diabetes | ATHEROSCLEROSIS |
| 2020 | Glucose Loading Enhances the Value of 18 F-FDG PET/CT for the Characterization and Delineation of Cerebral Gliomas
| CANCERS |
| 2020 | Response: Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus (Diabetes Metab J 2020;44:267-76)
| DIABETES & METABOLISM JOURNAL |
http://orcid.org/0000-0002-6219-4942
(56424219700)
